Login / Signup
Shirong Peng
ORCID
Publication Activity (10 Years)
Years Active: 2022-2022
Publications (10 Years): 1
Top Topics
Climate Change
Prostate Cancer
Atrial Fibrillation
Dna Damage Response
Top Venues
APL bioengineering
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Shirong Peng
,
Xinyu Zhang
,
Hao Huang
,
Bisheng Cheng
,
Zhi Xiong
,
Tao Du
,
Jun Wu
,
Hai Huang
Glutathione-sensitive nanoparticles enhance the combined therapeutic effect of checkpoint kinase 1 inhibitor and cisplatin in prostate cancer.
APL bioengineering
6 (4) (2022)